Augusta, Ga. – Dr. Alvin V. Terry Jr., Regents’ Professor and Director of the Small Animal Behavior Core at Georgia Regents University, has been named Chairman of the Department of Pharmacology and Toxicology at GRU’s Medical College of Georgia.
“Dr. Terry is a tremendous ambassador and leader in our medical school and his profession and we are very pleased that he has assumed this new leadership role,” said Dr. Peter F. Buckley, MCG Dean. “Dr. Terry routinely lends his expertise to essential academic issues such as promotion and tenure and lab animal services and his enthusiasm to educating the next generation of physicians and scientists and to finding better ways to treat common and devastating disorders of memory function.
“We also must again thank Dr. William Caldwell for his stalwart leadership of the department for nearly 30 years and for his continuing commitment to discovery and education,” Buckley said.
Terry is a member of the Editorial Advisory Board of the Journal of Pharmacology and Experimental Therapeutics, has served on numerous study sections of the National Institutes of Health, and two Veterans Affairs Special Emphasis Panels on research of Gulf War illness in veterans. He has served as a member of the Scientific Advisory Panel of the Environmental Protection Agency Federal Insecticide, Fungicide, and Rodenticide Act examining the health effects of the common pesticide chlorpyrifos and as a pharmaceutical company consultant.
The federally-funded pharmacologist joined the MCG faculty in 1992 immediately after completing his training and joined the University of Georgia College of Pharmacy faculty in 1994. He directed UGA’s Graduate Program in Clinical and Experimental Therapeutics from 1999-2005, began a joint appointment at MCG in 2003, and rejoined the MCG faculty fulltime two years later.
Terry’s researches the role of the neurotransmitter acetylcholine in memory dysfunction, including the impact of pharmaceutical and toxicological agents, such as chemical warfare agents. His lab also focuses on drug discovery and development strategies for the treatment of illnesses such as Alzheimer’s disease and schizophrenia. He is an educator at MCG and The Graduate School at GRU. Terry earned his doctorate in pharmacology at the University of South Carolina College of Pharmacy and completed his postdoctoral training at GRU.